Fabrazyme

In the US, Fabrazyme (agalsidase beta systemic) is a member of the drug class lysosomal enzymes and is used to treat Fabry Disease.

US matches:

• Fabrazyme

Ingredient matches for Fabrazyme

Agalsidase Beta

Agalsidase Beta is reported as an ingredient of Fabrazyme in the following countries:

• Australia


• Austria


• Belgium


• Canada


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Finland


• France


• Germany


• Greece


• Hungary


• Israel


• Italy


• Japan


• Luxembourg


• Netherlands


• Norway


• Slovakia


• Slovenia


• Spain


• Sweden


• Switzerland


• United States

International Drug Name Search